OPCO Inc.

Addus HomeCare Corporation Prices Initial Public Offering.
Investment Weekly News; 11/14/2009; 746 words; ...joint book-running managers, and Stephens Inc. acted as co-manager. The shares of...800) 792-2473 or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department...8563, or via email at EquityProspectus@opco.com. A registration statement relating...

Universal City Florida Holding Co. I and II Announce Tender Offer and Consent Solicitation for 8 3/8% Senior Notes Due 2010 and Floating Rate Senior Notes Due 2010.
Leisure & Travel Week; 11/14/2009; 1580 words; ...3/4% senior notes (the "Opco Notes") issued by Universal...Partners, Ltd. and UCDP Finance, Inc. representing a majority of the principal amount of such Opco Notes outstanding on the Consent...Documents. J.P. Morgan Securities Inc., Banc of America Securities...

BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care Conference.(Conference news)
Computer Weekly News; 11/12/2009; 654 words; BioReference Laboratories, Inc (NASDAQ:"BRLI") announced...veracast.com/webcasts/opco/healthcare09/51108419.cfm...About BioReference Laboratories, Inc. BRLI is the third largest full...BioReference Laboratories, Inc, BioReference Laboratories...

DJO Incorporated Announces Financial Results for Third Quarter 2009.(Financial report)
Biotech Week; 11/11/2009; 2008 words; ...DJOFL"), for the third quarter of 2009, ended September 26, 2009. ReAble Therapeutics, Inc. ("ReAble") acquired DJO Incorporated ("DJO Opco") in a transaction completed on November 20, 2007 (the "DJO Merger"). Following completion...

Curis to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 958 words; Curis, Inc. (NASDAQ: CRIS), a drug...York City (see also Curis, Inc.). Dan Passeri, Curis' President...veracast.com/webcasts/opco/healthcare09/14113292.cfm...curis.com. About Curis, Inc. Curis is a drug development...